Population-based study of familial medullary thyroid cancer

Familial Cancer

Volumn 1, Issue 1, 2001, Pages 45-49

  Hemminki, Kari ^a   Dong, Chuanhui ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Affected sibs; Medullary thyroid carcinoma; MEN 2; Pheochromocytoma

Indexed keywords

ADOLESCENT; ADRENAL CANCER; ADULT; AGE; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CHILD; CONTROLLED STUDY; DATA BASE; FAMILIAL CANCER; HIGH RISK POPULATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MULTIPLE ENDOCRINE NEOPLASIA; PARENT; PHEOCHROMOCYTOMA; POPULATION RESEARCH; PRIORITY JOURNAL; PROGENY; SWEDEN; THYROID MEDULLARY CARCINOMA;

ADOLESCENT; ADULT; CARCINOMA, MEDULLARY; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; DATABASES, FACTUAL; FAMILY; HUMANS; INFANT; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PEDIGREE; POISSON DISTRIBUTION; RISK ASSESSMENT; SWEDEN; THYROID NEOPLASMS;

EID: 0035760832     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011530202868     Document Type: Article

References (20)

1. Negri E, Ron E, Franceschi S et al. Pooled analysis of case-control studies of thyroid cancer. Cancer Causes Cont 1999; 10: 131-42.
2. Galanti M, Ekbom A, Grimelius L, Yuen J. Parental cancer and the risk of papillary and follicular thyroid carcinoma. Br J Cancer 1997; 75: 451-6.
3. Pettersson B, Adami H-O, Wilander E, Coleman M. Trends in thyroid cancer incidence in Sweden, 1958-1981, by histopathologic type. Int J Cancer 1991; 48: 28-33.
4. Eng C. RET Proto-oncogene in the development of human cancer. J Clin Oncol 1999; 17: 380-93.
5. Ponder B. Multiple endocrine neoplasia type 2. In Vogelstein B, Kinzler K (eds): The Genetic Basis of Human Cancer. New York: McGraw-Hill, 1998: 475-87.
6. Tomlinson G. Familial cancer syndromes and genetic counseling. In Walterhouse D, Cohen S (eds): Diagnostic and Therapeutic Advances in Pediatric Oncology. Boston: Kluwer, 1997: 63-97.
7. Easton D, Ponder M, Cummings T et al. The clinical and screening age-at-onset distribution for the MEN-2 syndrome. Am J Hum Genet 1989; 44: 208-15.
8. Eng C, Mulligan L. Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease. Hum Mutat 1997; 9: 97-109.
9. Hemminki K, Dong C. Familial relatioships in thyroid cancer by histopathological type. Int J Cancer 2000; 85: 201-5.
10. Hemminki K, Vaittinen P, Kyyrönen P. Age-specific familial risks in common cancers of the offspring. Int J Cancer 1998; 78: 172-5.
11. Hemminki K, Vaittinen P. Familial cancers in a nation-wide family-cancer database: age distribution and prevalence. Eur J Cancer 1999; 35: 1109-11.
12. Hemminki K, Vaittinen P. Familial breast cancer in the Family-Cancer Database. Int J Cancer 1998; 77: 386-91.
13. Hemminki K, Vaittinen P. National database of familial cancer in Sweden. Genet Epidemiol 1998; 15: 225-36.
14. Lupoli G, Vitale G, Caraglia M et al. Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet 1999; 353: 637-9.
15. Esteve J, Benhamou E, Raymond L. Statistical Methods in Cancer Research. Lyon: IARC, 1994.
16. Center for Epidemiology. Cancer Incidence in Sweden 1996. Stockholm, 1998.
17. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994; 86: 1600-7.
18. Stratton J, Pharoah P, Smith S et al. A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol 1998; 105: 493-9.
19. Aarnio M, Sankila R, Pukkala E et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999; 81: 214-8.
20. Vogelstein B, Kinzler KW (eds). The genetic basis of human cancer. New York: McGraw-Hill, 1998.